Impact of COVID-19 on people living with HIV: A review

by Sandeep Prabhu, Selvamuthu Poongulali, Nagalingeswaran Kumarasamy
Published 2020-11-01

Attitudes of Indian HIV Clinicians Toward Depression in People Living with HIV

by Brian T. Chan, Amrose Pradeep, Kenneth H. Mayer, Nagalingeswaran Kumarasamy
Published 2017-03-01

Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India

by Nagalingeswaran Kumarasamy, Sruthi Sundaram, Selvamuthu Poongulali, Chandrasekaran Ezhilarasi, Ambrose Pradeep, Devaraj Chitra
Published 2018-01-01

Pneumonia and Pleural Effusion due to Cryptococcus Laurentii in a Clinically Proven Case of AIDS

by Esaki Muthu Shankar, Nagalingeswaran Kumarasamy, Devaleenol Bella, Srinivasan Renuka, Hayath Kownhar, Solomon Suniti, Ramachandran Rajan, Usha Anand Rao
Published 2006-01-01

Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.

by David J Lee, Nagalingeswaran Kumarasamy, Stephen C Resch, Gomathi N Sivaramakrishnan, Kenneth H Mayer, Srikanth Tripathy, A David Paltiel, Kenneth A Freedberg, Krishna P Reddy
Published 2019-01-01

Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells.

by Suresh Pallikkuth, Rajendra Pahwa, Bagavathi Kausalya, Shanmugam Saravanan, Li Pan, R Vignesh, Syed Iqbal, Sunil S Solomon, Kailapuri G Murugavel, Selvamuthu Poongulali, Nagalingeswaran Kumarasamy, Savita Pahwa
Published 2018-01-01

The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.

by Mai T Pho, Soumya Swaminathan, Nagalingeswaran Kumarasamy, Elena Losina, C Ponnuraja, Lauren M Uhler, Callie A Scott, Kenneth H Mayer, Kenneth A Freedberg, Rochelle P Walensky
Published 2012-01-01

Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.

by Kartik K Venkatesh, Jessica E Becker, Nagalingeswaran Kumarasamy, Yoriko M Nakamura, Kenneth H Mayer, Elena Losina, Soumya Swaminathan, Timothy P Flanigan, Rochelle P Walensky, Kenneth A Freedberg
Published 2013-01-01

Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium

by Julie Jesson, Sophie Desmonde, Constantin T. Yiannoutsos, Gabriela Patten, Karen Malateste, Stephany N. Duda, Nagalingeswaran Kumarasamy, Marcel Yotebieng, Mary-Ann Davies, Beverly Musick, Valeriane Leroy, Andrea Ciaranello, IeDEA
Published 2020-05-01

Reliability, Validity, and Factor Structure of the Internalized AIDS-Related Stigma Scale in Southern India

by Brian T. Chan MD, MPH, Amrose Pradeep MBBS, Ezhilarasi Chandrasekaran MSc, Lakshmi Prasad MA, Vinothini Murugesan MSW, Nagalingeswaran Kumarasamy MBBS, PhD, Kenneth H. Mayer MD, Alexander C. Tsai MD, PhD
Published 2019-02-01

The Convergence of Disclosure Concerns and Poverty Contributes to Loss to HIV Care in India: A Qualitative Study

by Jared Perlo AB, Isabella Colocci AB, Sai Shanthanand Rajagopal AB, Theresa S. Betancourt ScD, MA, Amrose Pradeep MBBS, Kenneth H. Mayer MD, Nagalingeswaran Kumarasamy MBBS, PhD, Conall O’Cleirigh PhD, Brian T. Chan MD, MPH
Published 2020-06-01

Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.

by Lauren M Uhler, Nagalingeswaran Kumarasamy, Kenneth H Mayer, Anjali Saxena, Elena Losina, Malaisamy Muniyandi, Adam W Stoler, Zhigang Lu, Rochelle P Walensky, Timothy P Flanigan, Melissa A Bender, Kenneth A Freedberg, Soumya Swaminathan, CEPAC International investigators
Published 2010-09-01

Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infect...

by Janaki Amin, Mark A Boyd, Nagalingeswaran Kumarasamy, Cecilia L Moore, Marcello H Losso, Chidi A Nwizu, Lerato Mohapi, Stephen J Kerr, Annette H Sohn, Hedy Teppler, Boris Renjifo, Jean-Michel Molina, Sean Emery, David A Cooper
Published 2015-01-01

Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of...

by Janaki Amin, Mark A Boyd, Nagalingeswaran Kumarasamy, Cecilia L Moore, Marcello H Losso, Chidi A Nwizu, Lerato Mohapi, Stephen J Kerr, Annette H Sohn, Hedy Teppler, Boris Renjifo, Jean-Michel Molina, Sean Emery, David A Cooper, SECOND-LINE
Published 2015-01-01

Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.

by André R S Périssé, Laura Smeaton, Yun Chen, Alberto La Rosa, Ann Walawander, Apsara Nair, Beatriz Grinsztejn, Breno Santos, Cecilia Kanyama, James Hakim, Mulinda Nyirenda, Nagalingeswaran Kumarasamy, Umesh G Lalloo, Timothy Flanigan, Thomas B Campbell, Michael D Hughes, P E A R L S study team of the ACTG
Published 2013-01-01

The long-term outcomes of antiretroviral treatment initiated with mono or dual nucleoside reverse transcriptase inhibitors in HIV-1-infected children: an Asian observational study

by Orasri Wittawatmongkol, Thahira J. Mohamed, Thoa P.K. Le, Vibol Ung, Alan Maleesatharn, R.awiwan Hansudewechakul, Lam V. Nguyen, Nagalingeswaran Kumarasamy, Pagakrong Lumbiganon, Tavitiya Sudjaritruk, Torsak Bunupuradah, Nik K.N. Yusoff, Nia Kurniati, Moy S. Fong, Revathy Nallusamy, Azar Kariminia, Annette H. Sohn, Kulkanya Chokephaibulkit
Published 2015-07-01

Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial.

by Steven A Safren, Katie B Biello, Laura Smeaton, Matthew J Mimiaga, Ann Walawander, Javier R Lama, Aadia Rana, Mulinda Nyirenda, Virginia M Kayoyo, Wadzanai Samaneka, Anjali Joglekar, David Celentano, Ana Martinez, Jocelyn E Remmert, Aspara Nair, Umesh G Lalloo, Nagalingeswaran Kumarasamy, James Hakim, Thomas B Campbell, PEARLS (ACTG A5175) Study Team
Published 2014-01-01

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052.

by Philip J Palumbo, Ethan A Wilson, Estelle Piwowar-Manning, Marybeth McCauley, Theresa Gamble, Newton Kumwenda, Joseph Makhema, Nagalingeswaran Kumarasamy, Suwat Chariyalertsak, James G Hakim, Mina C Hosseinipour, Marineide G Melo, Sheela V Godbole, Jose H Pilotto, Beatriz Grinsztejn, Ravindre Panchia, Ying Q Chen, Myron S Cohen, Susan H Eshleman, Jessica M Fogel
Published 2017-01-01

Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD

by Jialun Zhou, Junko Tanuma, Romanee Chaiwarith, Christopher K. C. Lee, Matthew G. Law, Nagalingeswaran Kumarasamy, Praphan Phanuphak, Yi-Ming A. Chen, Sasisopin Kiertiburanakul, Fujie Zhang, Saphonn Vonthanak, Rossana Ditangco, Sanjay Pujari, Jun Yong Choi, Tuti Parwati Merati, Evy Yunihastuti, Patrick C. K. Li, Adeeba Kamarulzaman, Van Kinh Nguyen, Thi Thanh Thuy Pham, Poh Lian Lim
Published 2012-01-01

C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral th...

by Mark W Tenforde, Nikhil Gupte, David W Dowdy, David M Asmuth, Ashwin Balagopal, Richard B Pollard, Patcharaphan Sugandhavesa, Javier R Lama, Sandy Pillay, Sandra W Cardoso, Jyoti Pawar, Breno Santos, Cynthia Riviere, Noluthando Mwelase, Cecilia Kanyama, Johnstone Kumwenda, James G Hakim, Nagalingeswaran Kumarasamy, Robert Bollinger, Richard D Semba, Thomas B Campbell, Amita Gupta, ACTG PEARLS and NWCS 319 Study Group
Published 2015-01-01